Fees are Below Average compared to funds in the same category. T. Rowe Price Science And Technology Fd has an expense ratio of 0.80 percent. Risk is Average compared to funds in the same category ...

Evercore ISI analyst Vijay Kumar raised the firm’s price target on Exact Sciences (EXAS) to $70 from $60 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life ...

The average one-year price target for Kodiak Sciences (NasdaqGM:KOD) has been revised to $56.71 / share. This is an increase ...

BTIG analyst Mark Massaro lowered the firm’s price target on Exact Sciences (EXAS) to $65 from $82 and keeps a Buy rating on the shares. The company delivered a Q3 revenue miss and large guide-down, ...

BofA lowered the firm’s price target on Exact Sciences (EXAS) to $75 from $88 and keeps a Buy rating on the shares after the company announced Q3 results that fell short of expectations and lowered ...

Sight Sciences, Inc.'s share price has fallen by -13.3% in the past 3 weeks, despite reporting a narrower-than-expected net loss in Q1 and sticking to its 2023 guidance. Sight Sciences' key Q1 2023 ...

View Caris Life Sciences, Inc. CAI stock quote prices, financial information, real-time forecasts, and company news from CNN.